Global Human Coagulation Factor VIII Market Size, Manufacturers, Opportunities and Forecast to 2030
Summary
Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.
According to APO Research, The global Human Coagulation Factor VIII market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Human Coagulation Factor VIII include Shire (Baxter), Bayer, CSL, Pfizer, Grifols, Biogen, Octapharma, NovoNordisk and Greencross, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Coagulation Factor VIII, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Coagulation Factor VIII.
The Human Coagulation Factor VIII market size, estimations, and forecasts are provided in terms of sales volume (K Bottles) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Coagulation Factor VIII market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Coagulation Factor VIII market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Coagulation Factor VIII and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Coagulation Factor VIII.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Coagulation Factor VIII manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Human Coagulation Factor VIII in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.
According to APO Research, The global Human Coagulation Factor VIII market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Human Coagulation Factor VIII include Shire (Baxter), Bayer, CSL, Pfizer, Grifols, Biogen, Octapharma, NovoNordisk and Greencross, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Coagulation Factor VIII, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Coagulation Factor VIII.
The Human Coagulation Factor VIII market size, estimations, and forecasts are provided in terms of sales volume (K Bottles) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Coagulation Factor VIII market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Shire (Baxter)
- Bayer
- CSL
- Pfizer
- Grifols
- Biogen
- Octapharma
- NovoNordisk
- Greencross
- Kedrion
- BPL
- Hualan Bio
- RAAS
- Recombinant Factor VIII
- Plasma-derived Factor VIII
- Hemophilia A
- Spontanous / Trauma
- Surgical
- Other
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Coagulation Factor VIII market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Coagulation Factor VIII and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Coagulation Factor VIII.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Coagulation Factor VIII manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Human Coagulation Factor VIII in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Human Coagulation Factor VIII Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Human Coagulation Factor VIII Sales Estimates and Forecasts (2019-2030)
1.3 Human Coagulation Factor VIII Market by Type
1.3.1 Recombinant Factor VIII
1.3.2 Plasma-derived Factor VIII
1.4 Global Human Coagulation Factor VIII Market Size by Type
1.4.1 Global Human Coagulation Factor VIII Market Size Overview by Type (2019-2030)
1.4.2 Global Human Coagulation Factor VIII Historic Market Size Review by Type (2019-2024)
1.4.3 Global Human Coagulation Factor VIII Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Human Coagulation Factor VIII Sales Breakdown by Type (2019-2024)
1.5.2 Europe Human Coagulation Factor VIII Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Human Coagulation Factor VIII Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Human Coagulation Factor VIII Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Human Coagulation Factor VIII Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Human Coagulation Factor VIII Industry Trends
2.2 Human Coagulation Factor VIII Industry Drivers
2.3 Human Coagulation Factor VIII Industry Opportunities and Challenges
2.4 Human Coagulation Factor VIII Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Human Coagulation Factor VIII Revenue (2019-2024)
3.2 Global Top Players by Human Coagulation Factor VIII Sales (2019-2024)
3.3 Global Top Players by Human Coagulation Factor VIII Price (2019-2024)
3.4 Global Human Coagulation Factor VIII Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Human Coagulation Factor VIII Key Company Manufacturing Sites & Headquarters
3.6 Global Human Coagulation Factor VIII Company, Product Type & Application
3.7 Global Human Coagulation Factor VIII Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Human Coagulation Factor VIII Market CR5 and HHI
3.8.2 Global Top 5 and 10 Human Coagulation Factor VIII Players Market Share by Revenue in 2023
3.8.3 2023 Human Coagulation Factor VIII Tier 1, Tier 2, and Tier
4 HUMAN COAGULATION FACTOR VIII REGIONAL STATUS AND OUTLOOK
4.1 Global Human Coagulation Factor VIII Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Human Coagulation Factor VIII Historic Market Size by Region
4.2.1 Global Human Coagulation Factor VIII Sales in Volume by Region (2019-2024)
4.2.2 Global Human Coagulation Factor VIII Sales in Value by Region (2019-2024)
4.2.3 Global Human Coagulation Factor VIII Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Human Coagulation Factor VIII Forecasted Market Size by Region
4.3.1 Global Human Coagulation Factor VIII Sales in Volume by Region (2025-2030)
4.3.2 Global Human Coagulation Factor VIII Sales in Value by Region (2025-2030)
4.3.3 Global Human Coagulation Factor VIII Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 HUMAN COAGULATION FACTOR VIII BY APPLICATION
5.1 Human Coagulation Factor VIII Market by Application
5.1.1 Hemophilia A
5.1.2 Spontanous / Trauma
5.1.3 Surgical
5.1.4 Other
5.2 Global Human Coagulation Factor VIII Market Size by Application
5.2.1 Global Human Coagulation Factor VIII Market Size Overview by Application (2019-2030)
5.2.2 Global Human Coagulation Factor VIII Historic Market Size Review by Application (2019-2024)
5.2.3 Global Human Coagulation Factor VIII Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Human Coagulation Factor VIII Sales Breakdown by Application (2019-2024)
5.3.2 Europe Human Coagulation Factor VIII Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Human Coagulation Factor VIII Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Human Coagulation Factor VIII Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Human Coagulation Factor VIII Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Shire (Baxter)
6.1.1 Shire (Baxter) Comapny Information
6.1.2 Shire (Baxter) Business Overview
6.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Shire (Baxter) Human Coagulation Factor VIII Product Portfolio
6.1.5 Shire (Baxter) Recent Developments
6.2 Bayer
6.2.1 Bayer Comapny Information
6.2.2 Bayer Business Overview
6.2.3 Bayer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Human Coagulation Factor VIII Product Portfolio
6.2.5 Bayer Recent Developments
6.3 CSL
6.3.1 CSL Comapny Information
6.3.2 CSL Business Overview
6.3.3 CSL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CSL Human Coagulation Factor VIII Product Portfolio
6.3.5 CSL Recent Developments
6.4 Pfizer
6.4.1 Pfizer Comapny Information
6.4.2 Pfizer Business Overview
6.4.3 Pfizer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Human Coagulation Factor VIII Product Portfolio
6.4.5 Pfizer Recent Developments
6.5 Grifols
6.5.1 Grifols Comapny Information
6.5.2 Grifols Business Overview
6.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Grifols Human Coagulation Factor VIII Product Portfolio
6.5.5 Grifols Recent Developments
6.6 Biogen
6.6.1 Biogen Comapny Information
6.6.2 Biogen Business Overview
6.6.3 Biogen Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Biogen Human Coagulation Factor VIII Product Portfolio
6.6.5 Biogen Recent Developments
6.7 Octapharma
6.7.1 Octapharma Comapny Information
6.7.2 Octapharma Business Overview
6.7.3 Octapharma Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Octapharma Human Coagulation Factor VIII Product Portfolio
6.7.5 Octapharma Recent Developments
6.8 NovoNordisk
6.8.1 NovoNordisk Comapny Information
6.8.2 NovoNordisk Business Overview
6.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
6.8.4 NovoNordisk Human Coagulation Factor VIII Product Portfolio
6.8.5 NovoNordisk Recent Developments
6.9 Greencross
6.9.1 Greencross Comapny Information
6.9.2 Greencross Business Overview
6.9.3 Greencross Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Greencross Human Coagulation Factor VIII Product Portfolio
6.9.5 Greencross Recent Developments
6.10 Kedrion
6.10.1 Kedrion Comapny Information
6.10.2 Kedrion Business Overview
6.10.3 Kedrion Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Kedrion Human Coagulation Factor VIII Product Portfolio
6.10.5 Kedrion Recent Developments
6.11 BPL
6.11.1 BPL Comapny Information
6.11.2 BPL Business Overview
6.11.3 BPL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
6.11.4 BPL Human Coagulation Factor VIII Product Portfolio
6.11.5 BPL Recent Developments
6.12 Hualan Bio
6.12.1 Hualan Bio Comapny Information
6.12.2 Hualan Bio Business Overview
6.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Hualan Bio Human Coagulation Factor VIII Product Portfolio
6.12.5 Hualan Bio Recent Developments
6.13 RAAS
6.13.1 RAAS Comapny Information
6.13.2 RAAS Business Overview
6.13.3 RAAS Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
6.13.4 RAAS Human Coagulation Factor VIII Product Portfolio
6.13.5 RAAS Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Human Coagulation Factor VIII Sales by Country
7.1.1 North America Human Coagulation Factor VIII Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Human Coagulation Factor VIII Sales by Country (2019-2024)
7.1.3 North America Human Coagulation Factor VIII Sales Forecast by Country (2025-2030)
7.2 North America Human Coagulation Factor VIII Market Size by Country
7.2.1 North America Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Human Coagulation Factor VIII Market Size by Country (2019-2024)
7.2.3 North America Human Coagulation Factor VIII Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Human Coagulation Factor VIII Sales by Country
8.1.1 Europe Human Coagulation Factor VIII Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Human Coagulation Factor VIII Sales by Country (2019-2024)
8.1.3 Europe Human Coagulation Factor VIII Sales Forecast by Country (2025-2030)
8.2 Europe Human Coagulation Factor VIII Market Size by Country
8.2.1 Europe Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Human Coagulation Factor VIII Market Size by Country (2019-2024)
8.2.3 Europe Human Coagulation Factor VIII Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Human Coagulation Factor VIII Sales by Country
9.1.1 Asia-Pacific Human Coagulation Factor VIII Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Human Coagulation Factor VIII Sales by Country (2019-2024)
9.1.3 Asia-Pacific Human Coagulation Factor VIII Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Human Coagulation Factor VIII Market Size by Country
9.2.1 Asia-Pacific Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Human Coagulation Factor VIII Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Human Coagulation Factor VIII Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Human Coagulation Factor VIII Sales by Country
10.1.1 Latin America Human Coagulation Factor VIII Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Human Coagulation Factor VIII Sales by Country (2019-2024)
10.1.3 Latin America Human Coagulation Factor VIII Sales Forecast by Country (2025-2030)
10.2 Latin America Human Coagulation Factor VIII Market Size by Country
10.2.1 Latin America Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Human Coagulation Factor VIII Market Size by Country (2019-2024)
10.2.3 Latin America Human Coagulation Factor VIII Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Human Coagulation Factor VIII Sales by Country
11.1.1 Middle East and Africa Human Coagulation Factor VIII Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Human Coagulation Factor VIII Sales by Country (2019-2024)
11.1.3 Middle East and Africa Human Coagulation Factor VIII Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Human Coagulation Factor VIII Market Size by Country
11.2.1 Middle East and Africa Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Human Coagulation Factor VIII Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Human Coagulation Factor VIII Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Human Coagulation Factor VIII Value Chain Analysis
12.1.1 Human Coagulation Factor VIII Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Human Coagulation Factor VIII Production Mode & Process
12.2 Human Coagulation Factor VIII Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Human Coagulation Factor VIII Distributors
12.2.3 Human Coagulation Factor VIII Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Human Coagulation Factor VIII Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Human Coagulation Factor VIII Sales Estimates and Forecasts (2019-2030)
1.3 Human Coagulation Factor VIII Market by Type
1.3.1 Recombinant Factor VIII
1.3.2 Plasma-derived Factor VIII
1.4 Global Human Coagulation Factor VIII Market Size by Type
1.4.1 Global Human Coagulation Factor VIII Market Size Overview by Type (2019-2030)
1.4.2 Global Human Coagulation Factor VIII Historic Market Size Review by Type (2019-2024)
1.4.3 Global Human Coagulation Factor VIII Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Human Coagulation Factor VIII Sales Breakdown by Type (2019-2024)
1.5.2 Europe Human Coagulation Factor VIII Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Human Coagulation Factor VIII Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Human Coagulation Factor VIII Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Human Coagulation Factor VIII Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Human Coagulation Factor VIII Industry Trends
2.2 Human Coagulation Factor VIII Industry Drivers
2.3 Human Coagulation Factor VIII Industry Opportunities and Challenges
2.4 Human Coagulation Factor VIII Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Human Coagulation Factor VIII Revenue (2019-2024)
3.2 Global Top Players by Human Coagulation Factor VIII Sales (2019-2024)
3.3 Global Top Players by Human Coagulation Factor VIII Price (2019-2024)
3.4 Global Human Coagulation Factor VIII Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Human Coagulation Factor VIII Key Company Manufacturing Sites & Headquarters
3.6 Global Human Coagulation Factor VIII Company, Product Type & Application
3.7 Global Human Coagulation Factor VIII Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Human Coagulation Factor VIII Market CR5 and HHI
3.8.2 Global Top 5 and 10 Human Coagulation Factor VIII Players Market Share by Revenue in 2023
3.8.3 2023 Human Coagulation Factor VIII Tier 1, Tier 2, and Tier
4 HUMAN COAGULATION FACTOR VIII REGIONAL STATUS AND OUTLOOK
4.1 Global Human Coagulation Factor VIII Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Human Coagulation Factor VIII Historic Market Size by Region
4.2.1 Global Human Coagulation Factor VIII Sales in Volume by Region (2019-2024)
4.2.2 Global Human Coagulation Factor VIII Sales in Value by Region (2019-2024)
4.2.3 Global Human Coagulation Factor VIII Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Human Coagulation Factor VIII Forecasted Market Size by Region
4.3.1 Global Human Coagulation Factor VIII Sales in Volume by Region (2025-2030)
4.3.2 Global Human Coagulation Factor VIII Sales in Value by Region (2025-2030)
4.3.3 Global Human Coagulation Factor VIII Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 HUMAN COAGULATION FACTOR VIII BY APPLICATION
5.1 Human Coagulation Factor VIII Market by Application
5.1.1 Hemophilia A
5.1.2 Spontanous / Trauma
5.1.3 Surgical
5.1.4 Other
5.2 Global Human Coagulation Factor VIII Market Size by Application
5.2.1 Global Human Coagulation Factor VIII Market Size Overview by Application (2019-2030)
5.2.2 Global Human Coagulation Factor VIII Historic Market Size Review by Application (2019-2024)
5.2.3 Global Human Coagulation Factor VIII Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Human Coagulation Factor VIII Sales Breakdown by Application (2019-2024)
5.3.2 Europe Human Coagulation Factor VIII Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Human Coagulation Factor VIII Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Human Coagulation Factor VIII Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Human Coagulation Factor VIII Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Shire (Baxter)
6.1.1 Shire (Baxter) Comapny Information
6.1.2 Shire (Baxter) Business Overview
6.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Shire (Baxter) Human Coagulation Factor VIII Product Portfolio
6.1.5 Shire (Baxter) Recent Developments
6.2 Bayer
6.2.1 Bayer Comapny Information
6.2.2 Bayer Business Overview
6.2.3 Bayer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Human Coagulation Factor VIII Product Portfolio
6.2.5 Bayer Recent Developments
6.3 CSL
6.3.1 CSL Comapny Information
6.3.2 CSL Business Overview
6.3.3 CSL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CSL Human Coagulation Factor VIII Product Portfolio
6.3.5 CSL Recent Developments
6.4 Pfizer
6.4.1 Pfizer Comapny Information
6.4.2 Pfizer Business Overview
6.4.3 Pfizer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Human Coagulation Factor VIII Product Portfolio
6.4.5 Pfizer Recent Developments
6.5 Grifols
6.5.1 Grifols Comapny Information
6.5.2 Grifols Business Overview
6.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Grifols Human Coagulation Factor VIII Product Portfolio
6.5.5 Grifols Recent Developments
6.6 Biogen
6.6.1 Biogen Comapny Information
6.6.2 Biogen Business Overview
6.6.3 Biogen Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Biogen Human Coagulation Factor VIII Product Portfolio
6.6.5 Biogen Recent Developments
6.7 Octapharma
6.7.1 Octapharma Comapny Information
6.7.2 Octapharma Business Overview
6.7.3 Octapharma Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Octapharma Human Coagulation Factor VIII Product Portfolio
6.7.5 Octapharma Recent Developments
6.8 NovoNordisk
6.8.1 NovoNordisk Comapny Information
6.8.2 NovoNordisk Business Overview
6.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
6.8.4 NovoNordisk Human Coagulation Factor VIII Product Portfolio
6.8.5 NovoNordisk Recent Developments
6.9 Greencross
6.9.1 Greencross Comapny Information
6.9.2 Greencross Business Overview
6.9.3 Greencross Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Greencross Human Coagulation Factor VIII Product Portfolio
6.9.5 Greencross Recent Developments
6.10 Kedrion
6.10.1 Kedrion Comapny Information
6.10.2 Kedrion Business Overview
6.10.3 Kedrion Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Kedrion Human Coagulation Factor VIII Product Portfolio
6.10.5 Kedrion Recent Developments
6.11 BPL
6.11.1 BPL Comapny Information
6.11.2 BPL Business Overview
6.11.3 BPL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
6.11.4 BPL Human Coagulation Factor VIII Product Portfolio
6.11.5 BPL Recent Developments
6.12 Hualan Bio
6.12.1 Hualan Bio Comapny Information
6.12.2 Hualan Bio Business Overview
6.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Hualan Bio Human Coagulation Factor VIII Product Portfolio
6.12.5 Hualan Bio Recent Developments
6.13 RAAS
6.13.1 RAAS Comapny Information
6.13.2 RAAS Business Overview
6.13.3 RAAS Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
6.13.4 RAAS Human Coagulation Factor VIII Product Portfolio
6.13.5 RAAS Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Human Coagulation Factor VIII Sales by Country
7.1.1 North America Human Coagulation Factor VIII Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Human Coagulation Factor VIII Sales by Country (2019-2024)
7.1.3 North America Human Coagulation Factor VIII Sales Forecast by Country (2025-2030)
7.2 North America Human Coagulation Factor VIII Market Size by Country
7.2.1 North America Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Human Coagulation Factor VIII Market Size by Country (2019-2024)
7.2.3 North America Human Coagulation Factor VIII Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Human Coagulation Factor VIII Sales by Country
8.1.1 Europe Human Coagulation Factor VIII Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Human Coagulation Factor VIII Sales by Country (2019-2024)
8.1.3 Europe Human Coagulation Factor VIII Sales Forecast by Country (2025-2030)
8.2 Europe Human Coagulation Factor VIII Market Size by Country
8.2.1 Europe Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Human Coagulation Factor VIII Market Size by Country (2019-2024)
8.2.3 Europe Human Coagulation Factor VIII Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Human Coagulation Factor VIII Sales by Country
9.1.1 Asia-Pacific Human Coagulation Factor VIII Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Human Coagulation Factor VIII Sales by Country (2019-2024)
9.1.3 Asia-Pacific Human Coagulation Factor VIII Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Human Coagulation Factor VIII Market Size by Country
9.2.1 Asia-Pacific Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Human Coagulation Factor VIII Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Human Coagulation Factor VIII Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Human Coagulation Factor VIII Sales by Country
10.1.1 Latin America Human Coagulation Factor VIII Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Human Coagulation Factor VIII Sales by Country (2019-2024)
10.1.3 Latin America Human Coagulation Factor VIII Sales Forecast by Country (2025-2030)
10.2 Latin America Human Coagulation Factor VIII Market Size by Country
10.2.1 Latin America Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Human Coagulation Factor VIII Market Size by Country (2019-2024)
10.2.3 Latin America Human Coagulation Factor VIII Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Human Coagulation Factor VIII Sales by Country
11.1.1 Middle East and Africa Human Coagulation Factor VIII Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Human Coagulation Factor VIII Sales by Country (2019-2024)
11.1.3 Middle East and Africa Human Coagulation Factor VIII Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Human Coagulation Factor VIII Market Size by Country
11.2.1 Middle East and Africa Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Human Coagulation Factor VIII Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Human Coagulation Factor VIII Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Human Coagulation Factor VIII Value Chain Analysis
12.1.1 Human Coagulation Factor VIII Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Human Coagulation Factor VIII Production Mode & Process
12.2 Human Coagulation Factor VIII Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Human Coagulation Factor VIII Distributors
12.2.3 Human Coagulation Factor VIII Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
LIST OF TABLES
Table 1. Major Company of Recombinant Factor VIII
Table 2. Major Company of Plasma-derived Factor VIII
Table 3. Global Human Coagulation Factor VIII Sales by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 4. Global Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)
Table 5. Global Human Coagulation Factor VIII Sales Market Share in Volume by Type (2019-2024)
Table 6. Global Human Coagulation Factor VIII Sales by Type (2019-2024) & (US$ Million)
Table 7. Global Human Coagulation Factor VIII Sales Market Share in Value by Type (2019-2024)
Table 8. Global Human Coagulation Factor VIII Price by Type (2019-2024) & (USD/Bottle)
Table 9. Global Human Coagulation Factor VIII Sales by Type (2025-2030) & (K Bottles)
Table 10. Global Human Coagulation Factor VIII Sales Market Share in Volume by Type (2025-2030)
Table 11. Global Human Coagulation Factor VIII Sales by Type (2025-2030) & (US$ Million)
Table 12. Global Human Coagulation Factor VIII Sales Market Share in Value by Type (2025-2030)
Table 13. Global Human Coagulation Factor VIII Price by Type (2025-2030) & (USD/Bottle)
Table 14. North America Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)
Table 15. North America Human Coagulation Factor VIII Sales by Type (2019-2024) & (US$ Million)
Table 16. Europe Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)
Table 17. Europe Human Coagulation Factor VIII Sales by Type (2019-2024) & (US$ Million)
Table 18. Asia-Pacific Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)
Table 19. Asia-Pacific Human Coagulation Factor VIII Sales by Type (2019-2024) & (US$ Million)
Table 20. Latin America Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)
Table 21. Latin America Human Coagulation Factor VIII Sales by Type (2019-2024) & (US$ Million)
Table 22. Middle East and Africa Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)
Table 23. Middle East and Africa Human Coagulation Factor VIII Sales by Type (2019-2024) & (US$ Million)
Table 24. Human Coagulation Factor VIII Industry Trends
Table 25. Human Coagulation Factor VIII Industry Drivers
Table 26. Human Coagulation Factor VIII Industry Opportunities and Challenges
Table 27. Human Coagulation Factor VIII Industry Restraints
Table 28. Global Human Coagulation Factor VIII Sales Revenue by Company (US$ Million) & (2019-2024)
Table 29. Global Human Coagulation Factor VIII Revenue Market Share by Company (2019-2024)
Table 30. Global Human Coagulation Factor VIII Sales by Company (2019-2024) & (K Bottles)
Table 31. Global Human Coagulation Factor VIII Sales Share by Company (2019-2024)
Table 32. Global Human Coagulation Factor VIII Market Price by Company (2019-2024) & (USD/Bottle)
Table 33. Global Human Coagulation Factor VIII Industry Company Ranking, 2022 VS 2023 VS 2024
Table 34. Global Human Coagulation Factor VIII Key Company Manufacturing Sites & Headquarters
Table 35. Global Human Coagulation Factor VIII Company, Product Type & Application
Table 36. Global Human Coagulation Factor VIII Company Commercialization Time
Table 37. Global Company Market Concentration Ratio (CR5 and HHI)
Table 38. Global Human Coagulation Factor VIII by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 39. Global Human Coagulation Factor VIII Market Size Comparison by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Global Human Coagulation Factor VIII Sales by Region (2019-2024) & (K Bottles)
Table 41. Global Human Coagulation Factor VIII Sales Market Share in Volume by Region (2019-2024)
Table 42. Global Human Coagulation Factor VIII Sales by Region (2019-2024) & (US$ Million)
Table 43. Global Human Coagulation Factor VIII Sales Market Share in Value by Region (2019-2024)
Table 44. Global Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 45. Global Human Coagulation Factor VIII Sales by Region (2025-2030) & (K Bottles)
Table 46. Global Human Coagulation Factor VIII Sales Market Share in Volume by Region (2025-2030)
Table 47. Global Human Coagulation Factor VIII Sales by Region (2025-2030) & (US$ Million)
Table 48. Global Human Coagulation Factor VIII Sales Market Share in Value by Region (2025-2030)
Table 49. Global Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2025-2030)
Table 50. Global Human Coagulation Factor VIII Sales by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 51. Global Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)
Table 52. Global Human Coagulation Factor VIII Sales Market Share in Volume by Application (2019-2024)
Table 53. Global Human Coagulation Factor VIII Sales by Application (2019-2024) & (US$ Million)
Table 54. Global Human Coagulation Factor VIII Sales Market Share in Value by Application (2019-2024)
Table 55. Global Human Coagulation Factor VIII Price by Application (2019-2024) & (USD/Bottle)
Table 56. Global Human Coagulation Factor VIII Sales by Application (2025-2030) & (K Bottles)
Table 57. Global Human Coagulation Factor VIII Sales Market Share in Volume by Application (2025-2030)
Table 58. Global Human Coagulation Factor VIII Sales by Application (2025-2030) & (US$ Million)
Table 59. Global Human Coagulation Factor VIII Sales Market Share in Value by Application (2025-2030)
Table 60. Global Human Coagulation Factor VIII Price by Application (2025-2030) & (USD/Bottle)
Table 61. North America Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)
Table 62. North America Human Coagulation Factor VIII Sales by Application (2019-2024) & (US$ Million)
Table 63. Europe Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)
Table 64. Europe Human Coagulation Factor VIII Sales by Application (2019-2024) & (US$ Million)
Table 65. Asia-Pacific Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)
Table 66. Asia-Pacific Human Coagulation Factor VIII Sales by Application (2019-2024) & (US$ Million)
Table 67. Latin America Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)
Table 68. Latin America Human Coagulation Factor VIII Sales by Application (2019-2024) & (US$ Million)
Table 69. Middle East and Africa Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)
Table 70. Middle East and Africa Human Coagulation Factor VIII Sales by Application (2019-2024) & (US$ Million)
Table 71. Shire (Baxter) Company Information
Table 72. Shire (Baxter) Business Overview
Table 73. Shire (Baxter) Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 74. Shire (Baxter) Human Coagulation Factor VIII Product Portfolio
Table 75. Shire (Baxter) Recent Development
Table 76. Bayer Company Information
Table 77. Bayer Business Overview
Table 78. Bayer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 79. Bayer Human Coagulation Factor VIII Product Portfolio
Table 80. Bayer Recent Development
Table 81. CSL Company Information
Table 82. CSL Business Overview
Table 83. CSL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 84. CSL Human Coagulation Factor VIII Product Portfolio
Table 85. CSL Recent Development
Table 86. Pfizer Company Information
Table 87. Pfizer Business Overview
Table 88. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 89. Pfizer Human Coagulation Factor VIII Product Portfolio
Table 90. Pfizer Recent Development
Table 91. Grifols Company Information
Table 92. Grifols Business Overview
Table 93. Grifols Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 94. Grifols Human Coagulation Factor VIII Product Portfolio
Table 95. Grifols Recent Development
Table 96. Biogen Company Information
Table 97. Biogen Business Overview
Table 98. Biogen Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 99. Biogen Human Coagulation Factor VIII Product Portfolio
Table 100. Biogen Recent Development
Table 101. Octapharma Company Information
Table 102. Octapharma Business Overview
Table 103. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 104. Octapharma Human Coagulation Factor VIII Product Portfolio
Table 105. Octapharma Recent Development
Table 106. NovoNordisk Company Information
Table 107. NovoNordisk Business Overview
Table 108. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 109. NovoNordisk Human Coagulation Factor VIII Product Portfolio
Table 110. NovoNordisk Recent Development
Table 111. Greencross Company Information
Table 112. Greencross Business Overview
Table 113. Greencross Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 114. Greencross Human Coagulation Factor VIII Product Portfolio
Table 115. Greencross Recent Development
Table 116. Kedrion Company Information
Table 117. Kedrion Business Overview
Table 118. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 119. Kedrion Human Coagulation Factor VIII Product Portfolio
Table 120. Kedrion Recent Development
Table 121. BPL Company Information
Table 122. BPL Business Overview
Table 123. BPL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 124. BPL Human Coagulation Factor VIII Product Portfolio
Table 125. BPL Recent Development
Table 126. Hualan Bio Company Information
Table 127. Hualan Bio Business Overview
Table 128. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 129. Hualan Bio Human Coagulation Factor VIII Product Portfolio
Table 130. Hualan Bio Recent Development
Table 131. RAAS Company Information
Table 132. RAAS Business Overview
Table 133. RAAS Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 134. RAAS Human Coagulation Factor VIII Product Portfolio
Table 135. RAAS Recent Development
Table 136. North America Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (K Bottles): 2019 VS 2023 VS 2030
Table 137. North America Human Coagulation Factor VIII Sales by Country (2019-2024) & (K Bottles)
Table 138. North America Human Coagulation Factor VIII Sales Market Share by Country (2019-2024)
Table 139. North America Human Coagulation Factor VIII Sales Forecast by Country (2025-2030) & (K Bottles)
Table 140. North America Human Coagulation Factor VIII Sales Market Share Forecast by Country (2025-2030)
Table 141. North America Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 142. North America Human Coagulation Factor VIII Market Size by Country (2019-2024) & (US$ Million)
Table 143. North America Human Coagulation Factor VIII Market Share by Country (2019-2024)
Table 144. North America Human Coagulation Factor VIII Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 145. North America Human Coagulation Factor VIII Market Share Forecast by Country (2025-2030)
Table 146. Europe Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (K Bottles): 2019 VS 2023 VS 2030
Table 147. Europe Human Coagulation Factor VIII Sales by Country (2019-2024) & (K Bottles)
Table 148. Europe Human Coagulation Factor VIII Sales Market Share by Country (2019-2024)
Table 149. Europe Human Coagulation Factor VIII Sales Forecast by Country (2025-2030) & (K Bottles)
Table 150. Europe Human Coagulation Factor VIII Sales Market Share Forecast by Country (2025-2030)
Table 151. Europe Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 152. Europe Human Coagulation Factor VIII Market Size by Country (2019-2024) & (US$ Million)
Table 153. Europe Human Coagulation Factor VIII Market Share by Country (2019-2024)
Table 154. Europe Human Coagulation Factor VIII Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 155. Europe Human Coagulation Factor VIII Market Share Forecast by Country (2025-2030)
Table 156. Asia-Pacific Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (K Bottles): 2019 VS 2023 VS 2030
Table 157. Asia-Pacific Human Coagulation Factor VIII Sales by Country (2019-2024) & (K Bottles)
Table 158. Asia-Pacific Human Coagulation Factor VIII Sales Market Share by Country (2019-2024)
Table 159. Asia-Pacific Human Coagulation Factor VIII Sales Forecast by Country (2025-2030) & (K Bottles)
Table 160. Asia-Pacific Human Coagulation Factor VIII Sales Market Share Forecast by Country (2025-2030)
Table 161. Asia-Pacific Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 162. Asia-Pacific Human Coagulation Factor VIII Market Size by Country (2019-2024) & (US$ Million)
Table 163. Asia-Pacific Human Coagulation Factor VIII Market Share by Country (2019-2024)
Table 164. Asia-Pacific Human Coagulation Factor VIII Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 165. Asia-Pacific Human Coagulation Factor VIII Market Share Forecast by Country (2025-2030)
Table 166. Latin America Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (K Bottles): 2019 VS 2023 VS 2030
Table 167. Latin America Human Coagulation Factor VIII Sales by Country (2019-2024) & (K Bottles)
Table 168. Latin America Human Coagulation Factor VIII Sales Market Share by Country (2019-2024)
Table 169. Latin America Human Coagulation Factor VIII Sales Forecast by Country (2025-2030) & (K Bottles)
Table 170. Latin America Human Coagulation Factor VIII Sales Market Share Forecast by Country (2025-2030)
Table 171. Latin America Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 172. Latin America Human Coagulation Factor VIII Market Size by Country (2019-2024) & (US$ Million)
Table 173. Latin America Human Coagulation Factor VIII Market Share by Country (2019-2024)
Table 174. Latin America Human Coagulation Factor VIII Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 175. Latin America Human Coagulation Factor VIII Market Share Forecast by Country (2025-2030)
Table 176. Middle East and Africa Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (K Bottles): 2019 VS 2023 VS 2030
Table 177. Middle East and Africa Human Coagulation Factor VIII Sales by Country (2019-2024) & (K Bottles)
Table 178. Middle East and Africa Human Coagulation Factor VIII Sales Market Share by Country (2019-2024)
Table 179. Middle East and Africa Human Coagulation Factor VIII Sales Forecast by Country (2025-2030) & (K Bottles)
Table 180. Middle East and Africa Human Coagulation Factor VIII Sales Market Share Forecast by Country (2025-2030)
Table 181. Middle East and Africa Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 182. Middle East and Africa Human Coagulation Factor VIII Market Size by Country (2019-2024) & (US$ Million)
Table 183. Middle East and Africa Human Coagulation Factor VIII Market Share by Country (2019-2024)
Table 184. Middle East and Africa Human Coagulation Factor VIII Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 185. Middle East and Africa Human Coagulation Factor VIII Market Share Forecast by Country (2025-2030)
Table 186. Key Raw Materials
Table 187. Raw Materials Key Suppliers
Table 188. Human Coagulation Factor VIII Distributors List
Table 189. Human Coagulation Factor VIII Customers List
Table 190. Research Programs/Design for This Report
Table 191. Authors List of This Report
Table 192. Secondary Sources
Table 193. Primary Sources
Table 1. Major Company of Recombinant Factor VIII
Table 2. Major Company of Plasma-derived Factor VIII
Table 3. Global Human Coagulation Factor VIII Sales by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 4. Global Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)
Table 5. Global Human Coagulation Factor VIII Sales Market Share in Volume by Type (2019-2024)
Table 6. Global Human Coagulation Factor VIII Sales by Type (2019-2024) & (US$ Million)
Table 7. Global Human Coagulation Factor VIII Sales Market Share in Value by Type (2019-2024)
Table 8. Global Human Coagulation Factor VIII Price by Type (2019-2024) & (USD/Bottle)
Table 9. Global Human Coagulation Factor VIII Sales by Type (2025-2030) & (K Bottles)
Table 10. Global Human Coagulation Factor VIII Sales Market Share in Volume by Type (2025-2030)
Table 11. Global Human Coagulation Factor VIII Sales by Type (2025-2030) & (US$ Million)
Table 12. Global Human Coagulation Factor VIII Sales Market Share in Value by Type (2025-2030)
Table 13. Global Human Coagulation Factor VIII Price by Type (2025-2030) & (USD/Bottle)
Table 14. North America Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)
Table 15. North America Human Coagulation Factor VIII Sales by Type (2019-2024) & (US$ Million)
Table 16. Europe Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)
Table 17. Europe Human Coagulation Factor VIII Sales by Type (2019-2024) & (US$ Million)
Table 18. Asia-Pacific Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)
Table 19. Asia-Pacific Human Coagulation Factor VIII Sales by Type (2019-2024) & (US$ Million)
Table 20. Latin America Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)
Table 21. Latin America Human Coagulation Factor VIII Sales by Type (2019-2024) & (US$ Million)
Table 22. Middle East and Africa Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)
Table 23. Middle East and Africa Human Coagulation Factor VIII Sales by Type (2019-2024) & (US$ Million)
Table 24. Human Coagulation Factor VIII Industry Trends
Table 25. Human Coagulation Factor VIII Industry Drivers
Table 26. Human Coagulation Factor VIII Industry Opportunities and Challenges
Table 27. Human Coagulation Factor VIII Industry Restraints
Table 28. Global Human Coagulation Factor VIII Sales Revenue by Company (US$ Million) & (2019-2024)
Table 29. Global Human Coagulation Factor VIII Revenue Market Share by Company (2019-2024)
Table 30. Global Human Coagulation Factor VIII Sales by Company (2019-2024) & (K Bottles)
Table 31. Global Human Coagulation Factor VIII Sales Share by Company (2019-2024)
Table 32. Global Human Coagulation Factor VIII Market Price by Company (2019-2024) & (USD/Bottle)
Table 33. Global Human Coagulation Factor VIII Industry Company Ranking, 2022 VS 2023 VS 2024
Table 34. Global Human Coagulation Factor VIII Key Company Manufacturing Sites & Headquarters
Table 35. Global Human Coagulation Factor VIII Company, Product Type & Application
Table 36. Global Human Coagulation Factor VIII Company Commercialization Time
Table 37. Global Company Market Concentration Ratio (CR5 and HHI)
Table 38. Global Human Coagulation Factor VIII by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 39. Global Human Coagulation Factor VIII Market Size Comparison by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Global Human Coagulation Factor VIII Sales by Region (2019-2024) & (K Bottles)
Table 41. Global Human Coagulation Factor VIII Sales Market Share in Volume by Region (2019-2024)
Table 42. Global Human Coagulation Factor VIII Sales by Region (2019-2024) & (US$ Million)
Table 43. Global Human Coagulation Factor VIII Sales Market Share in Value by Region (2019-2024)
Table 44. Global Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 45. Global Human Coagulation Factor VIII Sales by Region (2025-2030) & (K Bottles)
Table 46. Global Human Coagulation Factor VIII Sales Market Share in Volume by Region (2025-2030)
Table 47. Global Human Coagulation Factor VIII Sales by Region (2025-2030) & (US$ Million)
Table 48. Global Human Coagulation Factor VIII Sales Market Share in Value by Region (2025-2030)
Table 49. Global Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2025-2030)
Table 50. Global Human Coagulation Factor VIII Sales by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 51. Global Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)
Table 52. Global Human Coagulation Factor VIII Sales Market Share in Volume by Application (2019-2024)
Table 53. Global Human Coagulation Factor VIII Sales by Application (2019-2024) & (US$ Million)
Table 54. Global Human Coagulation Factor VIII Sales Market Share in Value by Application (2019-2024)
Table 55. Global Human Coagulation Factor VIII Price by Application (2019-2024) & (USD/Bottle)
Table 56. Global Human Coagulation Factor VIII Sales by Application (2025-2030) & (K Bottles)
Table 57. Global Human Coagulation Factor VIII Sales Market Share in Volume by Application (2025-2030)
Table 58. Global Human Coagulation Factor VIII Sales by Application (2025-2030) & (US$ Million)
Table 59. Global Human Coagulation Factor VIII Sales Market Share in Value by Application (2025-2030)
Table 60. Global Human Coagulation Factor VIII Price by Application (2025-2030) & (USD/Bottle)
Table 61. North America Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)
Table 62. North America Human Coagulation Factor VIII Sales by Application (2019-2024) & (US$ Million)
Table 63. Europe Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)
Table 64. Europe Human Coagulation Factor VIII Sales by Application (2019-2024) & (US$ Million)
Table 65. Asia-Pacific Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)
Table 66. Asia-Pacific Human Coagulation Factor VIII Sales by Application (2019-2024) & (US$ Million)
Table 67. Latin America Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)
Table 68. Latin America Human Coagulation Factor VIII Sales by Application (2019-2024) & (US$ Million)
Table 69. Middle East and Africa Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)
Table 70. Middle East and Africa Human Coagulation Factor VIII Sales by Application (2019-2024) & (US$ Million)
Table 71. Shire (Baxter) Company Information
Table 72. Shire (Baxter) Business Overview
Table 73. Shire (Baxter) Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 74. Shire (Baxter) Human Coagulation Factor VIII Product Portfolio
Table 75. Shire (Baxter) Recent Development
Table 76. Bayer Company Information
Table 77. Bayer Business Overview
Table 78. Bayer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 79. Bayer Human Coagulation Factor VIII Product Portfolio
Table 80. Bayer Recent Development
Table 81. CSL Company Information
Table 82. CSL Business Overview
Table 83. CSL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 84. CSL Human Coagulation Factor VIII Product Portfolio
Table 85. CSL Recent Development
Table 86. Pfizer Company Information
Table 87. Pfizer Business Overview
Table 88. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 89. Pfizer Human Coagulation Factor VIII Product Portfolio
Table 90. Pfizer Recent Development
Table 91. Grifols Company Information
Table 92. Grifols Business Overview
Table 93. Grifols Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 94. Grifols Human Coagulation Factor VIII Product Portfolio
Table 95. Grifols Recent Development
Table 96. Biogen Company Information
Table 97. Biogen Business Overview
Table 98. Biogen Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 99. Biogen Human Coagulation Factor VIII Product Portfolio
Table 100. Biogen Recent Development
Table 101. Octapharma Company Information
Table 102. Octapharma Business Overview
Table 103. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 104. Octapharma Human Coagulation Factor VIII Product Portfolio
Table 105. Octapharma Recent Development
Table 106. NovoNordisk Company Information
Table 107. NovoNordisk Business Overview
Table 108. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 109. NovoNordisk Human Coagulation Factor VIII Product Portfolio
Table 110. NovoNordisk Recent Development
Table 111. Greencross Company Information
Table 112. Greencross Business Overview
Table 113. Greencross Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 114. Greencross Human Coagulation Factor VIII Product Portfolio
Table 115. Greencross Recent Development
Table 116. Kedrion Company Information
Table 117. Kedrion Business Overview
Table 118. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 119. Kedrion Human Coagulation Factor VIII Product Portfolio
Table 120. Kedrion Recent Development
Table 121. BPL Company Information
Table 122. BPL Business Overview
Table 123. BPL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 124. BPL Human Coagulation Factor VIII Product Portfolio
Table 125. BPL Recent Development
Table 126. Hualan Bio Company Information
Table 127. Hualan Bio Business Overview
Table 128. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 129. Hualan Bio Human Coagulation Factor VIII Product Portfolio
Table 130. Hualan Bio Recent Development
Table 131. RAAS Company Information
Table 132. RAAS Business Overview
Table 133. RAAS Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 134. RAAS Human Coagulation Factor VIII Product Portfolio
Table 135. RAAS Recent Development
Table 136. North America Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (K Bottles): 2019 VS 2023 VS 2030
Table 137. North America Human Coagulation Factor VIII Sales by Country (2019-2024) & (K Bottles)
Table 138. North America Human Coagulation Factor VIII Sales Market Share by Country (2019-2024)
Table 139. North America Human Coagulation Factor VIII Sales Forecast by Country (2025-2030) & (K Bottles)
Table 140. North America Human Coagulation Factor VIII Sales Market Share Forecast by Country (2025-2030)
Table 141. North America Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 142. North America Human Coagulation Factor VIII Market Size by Country (2019-2024) & (US$ Million)
Table 143. North America Human Coagulation Factor VIII Market Share by Country (2019-2024)
Table 144. North America Human Coagulation Factor VIII Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 145. North America Human Coagulation Factor VIII Market Share Forecast by Country (2025-2030)
Table 146. Europe Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (K Bottles): 2019 VS 2023 VS 2030
Table 147. Europe Human Coagulation Factor VIII Sales by Country (2019-2024) & (K Bottles)
Table 148. Europe Human Coagulation Factor VIII Sales Market Share by Country (2019-2024)
Table 149. Europe Human Coagulation Factor VIII Sales Forecast by Country (2025-2030) & (K Bottles)
Table 150. Europe Human Coagulation Factor VIII Sales Market Share Forecast by Country (2025-2030)
Table 151. Europe Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 152. Europe Human Coagulation Factor VIII Market Size by Country (2019-2024) & (US$ Million)
Table 153. Europe Human Coagulation Factor VIII Market Share by Country (2019-2024)
Table 154. Europe Human Coagulation Factor VIII Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 155. Europe Human Coagulation Factor VIII Market Share Forecast by Country (2025-2030)
Table 156. Asia-Pacific Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (K Bottles): 2019 VS 2023 VS 2030
Table 157. Asia-Pacific Human Coagulation Factor VIII Sales by Country (2019-2024) & (K Bottles)
Table 158. Asia-Pacific Human Coagulation Factor VIII Sales Market Share by Country (2019-2024)
Table 159. Asia-Pacific Human Coagulation Factor VIII Sales Forecast by Country (2025-2030) & (K Bottles)
Table 160. Asia-Pacific Human Coagulation Factor VIII Sales Market Share Forecast by Country (2025-2030)
Table 161. Asia-Pacific Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 162. Asia-Pacific Human Coagulation Factor VIII Market Size by Country (2019-2024) & (US$ Million)
Table 163. Asia-Pacific Human Coagulation Factor VIII Market Share by Country (2019-2024)
Table 164. Asia-Pacific Human Coagulation Factor VIII Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 165. Asia-Pacific Human Coagulation Factor VIII Market Share Forecast by Country (2025-2030)
Table 166. Latin America Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (K Bottles): 2019 VS 2023 VS 2030
Table 167. Latin America Human Coagulation Factor VIII Sales by Country (2019-2024) & (K Bottles)
Table 168. Latin America Human Coagulation Factor VIII Sales Market Share by Country (2019-2024)
Table 169. Latin America Human Coagulation Factor VIII Sales Forecast by Country (2025-2030) & (K Bottles)
Table 170. Latin America Human Coagulation Factor VIII Sales Market Share Forecast by Country (2025-2030)
Table 171. Latin America Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 172. Latin America Human Coagulation Factor VIII Market Size by Country (2019-2024) & (US$ Million)
Table 173. Latin America Human Coagulation Factor VIII Market Share by Country (2019-2024)
Table 174. Latin America Human Coagulation Factor VIII Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 175. Latin America Human Coagulation Factor VIII Market Share Forecast by Country (2025-2030)
Table 176. Middle East and Africa Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (K Bottles): 2019 VS 2023 VS 2030
Table 177. Middle East and Africa Human Coagulation Factor VIII Sales by Country (2019-2024) & (K Bottles)
Table 178. Middle East and Africa Human Coagulation Factor VIII Sales Market Share by Country (2019-2024)
Table 179. Middle East and Africa Human Coagulation Factor VIII Sales Forecast by Country (2025-2030) & (K Bottles)
Table 180. Middle East and Africa Human Coagulation Factor VIII Sales Market Share Forecast by Country (2025-2030)
Table 181. Middle East and Africa Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 182. Middle East and Africa Human Coagulation Factor VIII Market Size by Country (2019-2024) & (US$ Million)
Table 183. Middle East and Africa Human Coagulation Factor VIII Market Share by Country (2019-2024)
Table 184. Middle East and Africa Human Coagulation Factor VIII Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 185. Middle East and Africa Human Coagulation Factor VIII Market Share Forecast by Country (2025-2030)
Table 186. Key Raw Materials
Table 187. Raw Materials Key Suppliers
Table 188. Human Coagulation Factor VIII Distributors List
Table 189. Human Coagulation Factor VIII Customers List
Table 190. Research Programs/Design for This Report
Table 191. Authors List of This Report
Table 192. Secondary Sources
Table 193. Primary Sources
LIST OF FIGURES
Figure 1. Human Coagulation Factor VIII Product Picture
Figure 2. Global Human Coagulation Factor VIII Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Human Coagulation Factor VIII Market Size (2019-2030) & (US$ Million)
Figure 4. Global Human Coagulation Factor VIII Sales (2019-2030) & (K Bottles)
Figure 5. Product Picture of Recombinant Factor VIII
Figure 6. Global Recombinant Factor VIII Sales YoY Growth (2019-2030) & (K Bottles)
Figure 7. Product Picture of Plasma-derived Factor VIII
Figure 8. Global Plasma-derived Factor VIII Sales YoY Growth (2019-2030) & (K Bottles)
Figure 9. Global Human Coagulation Factor VIII Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 10. Global Human Coagulation Factor VIII Market Share by Type 2023 VS 2030
Figure 11. North America Human Coagulation Factor VIII Sales Market Share in Volume by Type in 2023
Figure 12. North America Human Coagulation Factor VIII Sales Market Share in Value by Type in 2023
Figure 13. Europe Human Coagulation Factor VIII Sales Market Share in Volume by Type in 2023
Figure 14. Europe Human Coagulation Factor VIII Sales Market Share in Value by Type in 2023
Figure 15. Asia-Pacific Human Coagulation Factor VIII Sales Market Share in Volume by Type in 2023
Figure 16. Asia-Pacific Human Coagulation Factor VIII Sales Market Share in Value by Type in 2023
Figure 17. Latin America Human Coagulation Factor VIII Sales Market Share in Volume by Type in 2023
Figure 18. Latin America Human Coagulation Factor VIII Sales Market Share in Value by Type in 2023
Figure 19. Middle East and Africa Human Coagulation Factor VIII Sales Market Share in Volume by Type in 2023
Figure 20. Middle East and Africa Human Coagulation Factor VIII Sales Market Share in Value by Ty
Figure 1. Human Coagulation Factor VIII Product Picture
Figure 2. Global Human Coagulation Factor VIII Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Human Coagulation Factor VIII Market Size (2019-2030) & (US$ Million)
Figure 4. Global Human Coagulation Factor VIII Sales (2019-2030) & (K Bottles)
Figure 5. Product Picture of Recombinant Factor VIII
Figure 6. Global Recombinant Factor VIII Sales YoY Growth (2019-2030) & (K Bottles)
Figure 7. Product Picture of Plasma-derived Factor VIII
Figure 8. Global Plasma-derived Factor VIII Sales YoY Growth (2019-2030) & (K Bottles)
Figure 9. Global Human Coagulation Factor VIII Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 10. Global Human Coagulation Factor VIII Market Share by Type 2023 VS 2030
Figure 11. North America Human Coagulation Factor VIII Sales Market Share in Volume by Type in 2023
Figure 12. North America Human Coagulation Factor VIII Sales Market Share in Value by Type in 2023
Figure 13. Europe Human Coagulation Factor VIII Sales Market Share in Volume by Type in 2023
Figure 14. Europe Human Coagulation Factor VIII Sales Market Share in Value by Type in 2023
Figure 15. Asia-Pacific Human Coagulation Factor VIII Sales Market Share in Volume by Type in 2023
Figure 16. Asia-Pacific Human Coagulation Factor VIII Sales Market Share in Value by Type in 2023
Figure 17. Latin America Human Coagulation Factor VIII Sales Market Share in Volume by Type in 2023
Figure 18. Latin America Human Coagulation Factor VIII Sales Market Share in Value by Type in 2023
Figure 19. Middle East and Africa Human Coagulation Factor VIII Sales Market Share in Volume by Type in 2023
Figure 20. Middle East and Africa Human Coagulation Factor VIII Sales Market Share in Value by Ty
